Innova Biosciences Limited is pleased to announce that Dr Andrew Lane has joined the company as International Licensing Manager.
Online PR News – 05-September-2012 – Lincolnshire, UK, Spetember 05, 2012 – Innova Biosciences Limited (Cambridge, UK) is pleased to announce that Dr Andrew Lane has joined the company as International Licensing Manager.
Andrew brings a wealth of experience having worked in the Biotech industry for more than 18 years. He has negotiated over 200 license and supply agreements on an international basis, with a diverse range of partners including university technology transfer offices, IVD companies and major Life Science businesses. These agreements have been key revenue drivers, generating multi-million pound sales over their lifetime.
Discussing the appointment Nick Gee – CEO of Innova Biosciences said ‘I’m delighted to welcome Andrew to Innova Biosciences. As the company continues to expand, it is essential that we maintain a highly experienced executive team with the skills to deliver our growth objectives. Andrew will play a key role in the advancement and commercialization of Innova’s novel antibody labelling technologies, especially in the diagnostics sector.
Andrew commented – ‘I am very pleased to be joining Innova Biosciences at an exciting time in their development and look forward to helping to support the next phase of their growth founded on award winning products with an increasing range of applications.’
About Innova Biosciences Limited:
Innova Biosciences is a growing, dynamic business based in Cambridge, UK. At the core of Innova's business are Lightning-Link® and InnovaCoat™ technologies that simplify the production of antibody-based reagents. The expanding Lightning-Link® and InnovaCoat™ portfolio is sold to research laboratories, pharmaceutical companies, biotechnology companies and diagnostic companies worldwide. For more information, please see http://www.innovabiosciences.com.